The difference in the results may, therefore, be attributed to different subjects (subjects without known acute or chronic disease except for obesity in Haridas’ study vs. patients with T2D in ours) and duration of insulin exposure (3–6 hours in Haridas’ study vs. 3 month in ours). This evidence concerns the gene INS and obesity disorder.